These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 38016356)

  • 61. Nanomaterials as Smart Immunomodulator Delivery System for Enhanced Cancer Therapy.
    Yuan C; Liu Y; Wang T; Sun M; Chen X
    ACS Biomater Sci Eng; 2020 Sep; 6(9):4774-4798. PubMed ID: 33455212
    [TBL] [Abstract][Full Text] [Related]  

  • 62. FOXC2 Promotes Oxaliplatin Resistance by Inducing Epithelial-Mesenchymal Transition via MAPK/ERK Signaling in Colorectal Cancer.
    Chen Y; Deng G; Fu Y; Han Y; Guo C; Yin L; Cai C; Shen H; Wu S; Zeng S
    Onco Targets Ther; 2020; 13():1625-1635. PubMed ID: 32110058
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Antitumour effects of a solid lipid nanoparticle loaded with gemcitabine and oxaliplatin on the viability, apoptosis, autophagy, and Hsp90 of ovarian cancer cells.
    Al-Mutairi AA; Alkhatib MH
    J Microencapsul; 2022 Aug; 39(5):467-480. PubMed ID: 35916335
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Nanobiotechnology-based strategies in alleviation of chemotherapy-mediated cardiotoxicity.
    Luo X
    Environ Res; 2023 Dec; 238(Pt 2):116989. PubMed ID: 37633635
    [TBL] [Abstract][Full Text] [Related]  

  • 65. MRI-guided dual-responsive anti-tumor nanostructures for synergistic chemo-photothermal therapy and chemodynamic therapy.
    Shi Y; Zhou M; Zhang Y; Wang Y; Cheng J
    Acta Biomater; 2023 Mar; 158():571-582. PubMed ID: 36586501
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Iron-based metal-organic framework co-loaded with buthionine sulfoximine and oxaliplatin for enhanced cancer chemo-ferrotherapy via sustainable glutathione elimination.
    Rao Z; Xia Y; Jia Q; Zhu Y; Wang L; Liu G; Liu X; Yang P; Ning P; Zhang R; Zhang X; Qiao C; Wang Z
    J Nanobiotechnology; 2023 Aug; 21(1):265. PubMed ID: 37563614
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The structural maintenance of chromosomes 5 is a possible biomarker for individualized treatment of colorectal cancer.
    Gong X; Tian X; Xie H; Li Z
    Cancer Med; 2023 Feb; 12(3):3276-3287. PubMed ID: 35894836
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Methotrexate-based amphiphilic prodrug nanoaggregates for co-administration of multiple therapeutics and synergistic cancer therapy.
    Hou M; Gao YE; Shi X; Bai S; Ma X; Li B; Xiao B; Xue P; Kang Y; Xu Z
    Acta Biomater; 2018 Sep; 77():228-239. PubMed ID: 30006314
    [TBL] [Abstract][Full Text] [Related]  

  • 69. PBK/TOPK promotes chemoresistance to oxaliplatin in hepatocellular carcinoma cells by regulating PTEN.
    Cao H; Yang M; Yang Y; Fang J; Cui Y
    Acta Biochim Biophys Sin (Shanghai); 2021 Apr; 53(5):584-592. PubMed ID: 33772548
    [TBL] [Abstract][Full Text] [Related]  

  • 70. PARP1 Inhibitor Combined With Oxaliplatin Efficiently Suppresses Oxaliplatin Resistance in Gastric Cancer-Derived Organoids via Homologous Recombination and the Base Excision Repair Pathway.
    Li H; Wang C; Lan L; Wu W; Evans I; Ruiz EJ; Yan L; Zhou Z; Oliveira JM; Reis RL; Hu Z; Chen W; Behrens A; He Y; Zhang C
    Front Cell Dev Biol; 2021; 9():719192. PubMed ID: 34497808
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Acid ceramidase inhibition sensitizes human colon cancer cells to oxaliplatin through downregulation of transglutaminase 2 and β1 integrin/FAK-mediated signalling.
    Klobučar M; Grbčić P; Pavelić SK; Jonjić N; Visentin S; Sedić M
    Biochem Biophys Res Commun; 2018 Sep; 503(2):843-848. PubMed ID: 29920241
    [TBL] [Abstract][Full Text] [Related]  

  • 72. PFKFB3 Inhibition Attenuates Oxaliplatin-Induced Autophagy and Enhances Its Cytotoxicity in Colon Cancer Cells.
    Yan S; Zhou N; Zhang D; Zhang K; Zheng W; Bao Y; Yang W
    Int J Mol Sci; 2019 Oct; 20(21):. PubMed ID: 31671668
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Secretory clusterin contributes to oxaliplatin resistance by activating Akt pathway in hepatocellular carcinoma.
    Xiu P; Dong X; Dong X; Xu Z; Zhu H; Liu F; Wei Z; Zhai B; Kanwar JR; Jiang H; Li J; Sun X
    Cancer Sci; 2013 Mar; 104(3):375-82. PubMed ID: 23279642
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Oxymatrine synergistically enhances antitumor activity of oxaliplatin in colon carcinoma through PI3K/AKT/mTOR pathway.
    Liu Y; Bi T; Wang Z; Wu G; Qian L; Gao Q; Shen G
    Apoptosis; 2016 Dec; 21(12):1398-1407. PubMed ID: 27671687
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Co-delivery of daunomycin and oxaliplatin by biodegradable polymers for safer and more efficacious combination therapy.
    Xiao H; Li W; Qi R; Yan L; Wang R; Liu S; Zheng Y; Xie Z; Huang Y; Jing X
    J Control Release; 2012 Nov; 163(3):304-14. PubMed ID: 22698937
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Dual pH/reduction-responsive hybrid polymeric micelles for targeted chemo-photothermal combination therapy.
    Zhang L; Qin Y; Zhang Z; Fan F; Huang C; Lu L; Wang H; Jin X; Zhao H; Kong D; Wang C; Sun H; Leng X; Zhu D
    Acta Biomater; 2018 Jul; 75():371-385. PubMed ID: 29777957
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Nanoparticle-based drug delivery systems with platinum drugs for overcoming cancer drug resistance.
    Xie P; Wang Y; Wei D; Zhang L; Zhang B; Xiao H; Song H; Mao X
    J Mater Chem B; 2021 Jul; 9(26):5173-5194. PubMed ID: 34116565
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Shikonin potentiates therapeutic efficacy of oxaliplatin through reactive oxygen species-mediated intrinsic apoptosis and endoplasmic reticulum stress in oxaliplatin-resistant colorectal cancer cells.
    Zhang Z; Shen C; Zhou F; Zhang Y
    Drug Dev Res; 2023 May; 84(3):542-555. PubMed ID: 36779379
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Graphene-Based Smart Platforms for Combined Cancer Therapy.
    Gu Z; Zhu S; Yan L; Zhao F; Zhao Y
    Adv Mater; 2019 Mar; 31(9):e1800662. PubMed ID: 30039878
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Synergic Antitumor Effect of Photodynamic Therapy and Chemotherapy Mediated by Nano Drug Delivery Systems.
    Aghajanzadeh M; Zamani M; Rajabi Kouchi F; Eixenberger J; Shirini D; Estrada D; Shirini F
    Pharmaceutics; 2022 Jan; 14(2):. PubMed ID: 35214054
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.